The utility of pregnancy-associated plasma protein A for determination of prognosis in a cohort of patients with coronary artery disease-Reference-Cited by-同舟云学术

The utility of pregnancy-associated plasma protein A for determination of prognosis in a cohort of patients with coronary artery disease

Published:2015-08 Issue:8 Volume:9 Page:731-741
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Zengin Elvin¹,Sinning Christoph¹,Zeller Tanja¹,Rupprecht Hans-J²,Schnabel Renate B¹,Lackner Karl-J³,Blankenberg Stefan¹,Westermann Dirk¹,Bickel Christoph⁴,

Affiliation:

1. Department of General & Interventional Cardiology, University Heart Center Hamburg, Martinistr. 52, 20246 Hamburg, Germany

2. Department of Medicine II, GPR Rüsselsheim, August-Bebel-Straße 59, 65428 Rüsselsheim, Germany

3. Institute of Clinical Chemistry & Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, 55131 Mainz, Germany

4. Department of Internal Medicine, Federal Armed Forces Central Hospital, Rübenacher Straße 170, 56072 Koblenz, Germany

Abstract

Background: Pregnancy-associated plasma protein-A (PAPP-A) is discussed as a biomarker representing unstable plaques in coronary artery disease (CAD). Methods: In this study 927 patients with CAD (534 with stable angina and 393 with acute coronary syndrome [ACS]) and 217 patients without CAD and measured PAPP-A levels were included. Follow-up for a median of 5 years was documented. Results: Rising quartiles of PAPP-A concentration had a higher cardiovascular mortality in the overall cohort of patients with CAD (p = 0.002) and the cohort with ACS (p = 0.01). Patients with suspected ACS below the LOD for troponin I but elevated PAPP-A levels had an increased cardiovascular mortality. A cut-off of 11.4 IU/l identified patients with a higher mortality during follow-up. Conclusion: Rising PAPP-A levels are prognostic in patients with CAD. PAPP-A levels were especially predictive in ACS patients with troponin below 10% CV of the 99th percentile for cardiovascular mortality.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/BMM.15.41

Reference33 articles.

1. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A

2. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein

3. The Insulin-Like Growth Factor Axis

4. Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty

5. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of pregnancy associated plasma protein‐A and neopterin levels in Behçet's patients;Dermatologic Therapy;2020-05-13

2. Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study;Journal of Clinical Medicine;2020-01-18

3. Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A);The Journal of Applied Laboratory Medicine;2018-11-01

4. Pregnancy-associated plasma protein-A in atherosclerosis: Molecular marker, mechanistic insight, and therapeutic target;Atherosclerosis;2018-11

5. Elevated PAPP-A levels in lean patients with polycystic ovary syndrome;Taiwanese Journal of Obstetrics and Gynecology;2018-06